Abstract
The technique of quantitative determination of a new compound, possessing anxiolytic activity, GML-1 in the blood plasma of rats is developed and validated. The analysis is performed by HPLC–MS. The method is linear in the range of 50–1000 ng/mL. 83.63% of GML-1 was recovered. The detection limit was 25 ng/mL.
Similar content being viewed by others
References
Yarkova, M.A., Mokrov, G.V., Gudasheva, T.A., et al., Pharm. Chem. J., 2016, vol. 50, no. 8, p.501.
Zherdev, V.P. and Litvin, A.A., Klin. Farmakokin., 2005, no. 2, p.1.
Novitskaya, Ya.G., Litvin, A.A., Zherdev, V.P., et al., Moscow Univ. Chem. Bull. (Engl. Transl.), 2013, vol. 68, no. 1, p.47.
Validierung analytischer Vervahren der fiktiven Firma “Muster” für die Arzneimittel-Herstellung (Validation of Analytical Procedures of “Muster” Fictitious Company for the Production of Drugs), Berlin: Bundesverband der Arzneimittel-Hersteller (BAH), 2004.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.A. Novitskiy, P.O. Bochkov, A.A. Litvin, V.P. Zherdev, E.V. Blynskaya, 2018, published in Vestnik Moskovskogo Universiteta, Seriya 2: Khimiya, 2018, No. 1, pp. 43–45.
About this article
Cite this article
Novitskiy, A.A., Bochkov, P.O., Litvin, A.A. et al. Development and Validation of the Quantification of GML-1 Compound (N-benzyl-N-methyl-1-phenylpyrrolo[1,2-A] pyrazine- 3-carbamide) in the Blood Plasma of Rats by HPLC–MS. Moscow Univ. Chem. Bull. 72, 322–324 (2017). https://doi.org/10.3103/S0027131418010042
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0027131418010042